Most cited papers from Sterna Biologicals (Germany)
What are the most cited papers from Sterna Biologicals (Germany)?
The most cited paper from Sterna Biologicals (Germany) is "Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme" (Norbert Krug et al., 2015), with 324 citations. Next come "Effective prevention and therapy of experimental allergic asthma using a GATA-3–specific DNAzyme" (106) and "Amphiphilic Biodegradable PEG-PCL-PEI Triblock Copolymers for FRET-Capable in Vitro and in Vivo Delivery of siRNA and Quantum Dots" (88).
Showing 25 of 25 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme Norbert Krug et al. · New England Journal of Medicine | 17 May 2015 | 324 |
| 2 | Effective prevention and therapy of experimental allergic asthma using a GATA-3–specific DNAzyme Serdar Sel, Michael Wegmann, Tanja Dicke et al. · Journal of Allergy and Clinical Immunology | 7 Mar 2008 | 106 |
| 3 | Amphiphilic Biodegradable PEG-PCL-PEI Triblock Copolymers for FRET-Capable in Vitro and in Vivo Delivery of siRNA and Quantum Dots Thomas Endres, Mengyao Zheng, Ayşe Kılıç et al. · Molecular Pharmaceutics | 4 Mar 2014 | 88 |
| 4 | Development of multiple W/O/W emulsions as dermal carrier system for oligonucleotides: Effect of additives on emulsion stability Thomas Schmidts, Dorota Dobler, Peggy Schlupp et al. · International Journal of Pharmaceutics | 3 Aug 2010 | 78 |
| 5 | Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice Vanessa Popp, Katharina Gerlach, Stefanie Mott et al. · Gastroenterology | 15 Sep 2016 | 74 |
| 6 | Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma Ursula Homburg, Harald Renz, Wolfgang Timmer et al. · Journal of Allergy and Clinical Immunology | 5 Apr 2015 | 49 |
| 7 | A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial Timm Greulich, Jens Michael Hohlfeld, Petra Neuser et al. · Respiratory Research | 4 Apr 2018 | 38 |
| 8 | Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs Agnieszka M. Turowska, Damiano Librizzi, Nadja Baumgartl et al. · Toxicology and Applied Pharmacology | 29 Jun 2013 | 26 |
| 9 | Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme Thomas Schmidts, Dorota Dobler, Sylvia von den Hoff et al. · International Journal of Pharmaceutics | 2 Apr 2011 | 25 |
| 10 | Clinical Expert Panel on Monitoring Potential Lung Toxicity of Inhaled Oligonucleotides: Consensus Points and Recommendations Eric W.F.W. Alton, Homer A. Boushey, Holger Garn et al. · Nucleic Acid Therapeutics | 18 Jul 2012 | 25 |
| 11 | Development of drug delivery systems for the dermal application of therapeutic DNAzymes Thomas Schmidts, Kay Marquardt, Peggy Schlupp et al. · International Journal of Pharmaceutics | 15 Apr 2012 | 23 |
| 12 | Toxicity profile of the GATA-3-specific DNAzyme hgd40 after inhalation exposure Rainer Fuhst, Frank E. Runge, Jochen Buschmann et al. · Pulmonary Pharmacology & Therapeutics | 20 Dec 2012 | 20 |
| 13 | Absence of Unspecific Innate Immune Cell Activation by GATA-3-Specific DNAzymes Tanja Dicke, Isabella Pali‐Schöll, Andreas Martin Kaufmann et al. · Nucleic Acid Therapeutics | Apr 2012 | 19 |
| 14 | Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients Norbert Krug, Jens Michael Hohlfeld, Roland Buhl et al. · Journal of Allergy and Clinical Immunology | 22 Mar 2017 | 18 |
| 15 | Flow Cytometry-Based Cell Type-Specific Assessment of Target Regulation by Pulmonary siRNA Delivery Olivia M. Merkel, Leigh Matthew Marsh, Holger Garn et al. · Methods in molecular biology | 14 Sep 2012 | 8 |
| 16 | Efficacy of T-cell transcription factor–specific DNAzymes in murine skin inflammation models Ulrich Purath, Rouba Ibrahim, Jana Zeitvogel et al. · Journal of Allergy and Clinical Immunology | 10 Nov 2015 | 7 |
| 17 | Effects of interference with GATA‐3 expression by target‐specific DNAzyme treatment on disease progression in a subacute oxazolone‐induced mouse model of atopic dermatitis Rouba Ibrahim, Ulrich Purath, Agnieszka M. Turowska et al. · Clinical and Translational Allergy | 11 Mar 2015 | 3 |
| 18 | Praetextatus – Verteidiger des römischen Glaubens? Zur gesellschaftlichen (Neu-)Inszenierung römischer Religion in Macrobius' Saturnalien Christa Frateantonio · Zeitschrift für Antikes Christentum / Journal of Ancient Christianity | 10 Aug 2007 | 2 |
| 19 | Der TH1 Transkriptionsfaktor T-bet als neues Target für die Morbus Crohn Therapie Vanessa Popp, Katharina Gerlach, Agnieszka M. Turowska et al. · Zeitschrift für Gastroenterologie | 9 May 2017 | 1 |
| 20 | Preclinical and Early Clinical Development of a GATA-3-Specific Dnazyme Intended for the Treatment of Th2-Driven Asthma Agnieszka M. Turowska, Ursula Homburg, Jens Kuhlmann et al. · Journal of Allergy and Clinical Immunology | 26 Jan 2013 | 1 |
| 21 | Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial Raja Atreya, Tanja Kühbacher, Michael Vieth et al. · Inflammatory Bowel Diseases | 9 May 2026 | 0 |
| 22 | Impact of a Digital Inhalation Coach on Inhalation Errors and Asthma Control Laura J. Arendsen, Kai M. Beeh, Philipp Kroneberg et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | 16 Dec 2025 | 0 |
| 23 | Influence of cigarette-smoke extract conditioned medium on CD4+ T cell differentiation in vitro Nadja Baumgartl, Agnieszka M. Turowska, Holger Garn · Pneumologie | 11 Feb 2014 | 0 |
| 24 | Distribution and efficacy of a GATA-3-specific DNAzyme in experimental allergic asthma models Agnieszka M. Turowska, Tanja Dicke, Nadja Baumgartl et al. · Pneumologie | 31 May 2012 | 0 |
| 25 | Autoimmune induction of a COPD-like inflammatory phenotype in mice Nadja Baumgartl, A Turowska, N Weißmann et al. · Pneumologie | 31 May 2012 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.